# Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess

> **NCT01537783** · PHASE4 · COMPLETED · sponsor: **Tufts Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Cutaneous Abscess

## Interventions

- **DRUG:** Chlorhexidine gluconate
- **DRUG:** Mupirocin

## Key facts

- **NCT ID:** NCT01537783
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01537783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01537783, "Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01537783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*